𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine

✍ Scribed by Theodore S. Lawrence; Emily Y. Chang; Tina M. Hahn; Larry W. Hertel; Donna.S. Shewach

Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
868 KB
Volume
34
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Determination of the Antimetabolite Gemc
Determination of the Antimetabolite Gemcitabine (2′,2′-Difluoro-2′-deoxycytidine) and of 2′,2′-Difluoro-2′-deoxyuridine by 19F Nuclear Magnetic Resonance Spectroscopy
✍ H.T. Edzes; G.J. Peters; P. Noordhuis; J.B. Vermorken 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 483 KB

The analysis of the new antimetabolite 2 ', 2 '-difluoro2 '-deoxycytidine (Gemcitabine, Eli Lilly Corp.) and of its metabolic deamination product, \(2^{\prime}, 2^{\prime}\)-difluoro-2'deoxyuridine, in urine and plasma by means of \({ }^{19} \mathrm{~F}\) NMR is described. Both compounds show AB-typ

Analysis of genes upregulated by the dem
Analysis of genes upregulated by the demethylating agent 5-aza-2′-deoxycytidine in gastric cancer cell lines
✍ Rintaro Mikata; Osamu Yokosuka; Kenichi Fukai; Fumio Imazeki; Makoto Arai; Motoh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 468 KB

## Abstract In gastric cancer, increasing numbers of genes have been reported to be silenced by aberrant methylation. However, global analysis of epigenetic inactivation in cancer cells has rarely been performed. For screening the genes upregulated by the demethylating agent 5‐aza‐2′‐deoxycytidine